ABSTRACT
Objective To analyze the clinical characteristics and risk factors of ( acute myocardial infarction , AMI ) in elderly patients with ( hyperuricemia , HUA) in Suzhou, and to provide a theoretical basis for the prevention and treatment of AMI in patients with HUA. Methods Among of 356 patients with hyperuricemia aged ≥60 years who were admitted to Suzhou Jiulong Hospital from January 2016 to December 2021 were selected. The patients were divided into control group and AMI group according to whether they were complicated with AMI. The clinical data of the patients were collected from the medical record system, and the types of AMI and the lesions of the three main coronary vessels in patients with HUA were statistically analyzed. The serum BNP level and LVEF value of the two groups were compared. Univariate analysis and logistic regression analysis were conducted to analyze the risk factors of AMI in patients with HUA. Results Fifty-five cases (15.45%) of 356 patients with HUA developed AMI, including 31 males and 24 females. There were 26 patients (47.27%) with NSTEMI and 29 patients (52.73%) with STEMI. In addition, 30 cases (54.55%) had three-vessel lesions. Compared with the control group, the male ratio, average age, smoking history ratio, systolic blood pressure, FPG, LDL-C and Hcy levels in the AMI group were significantly increased (P<0.05), while LVEF values decreased (P<0.05). Smoking history (OR=2.987), high LDL-C (OR=3.439), high Hcy (OR=2.672) and high FPG (OR=3.874) were risk factors for AMI in patients with HUA (P<0.05). Conclusion HUA patients in Suzhou area have a high risk of AMI, and most of them are STEMI patients, with the characteristics of multi vessel branch lesions. For HUA patients with smoking history, poor control of Hcy, LDL-C and FPG, the risk of AMI is higher. Smoking cessation and control of LDL-C, Hcy and FPG levels should be actively adopted to reduce the risk of AMI.
ABSTRACT
Objective:To explore the value of the constructed prognostic prediction model of resectable lung cancer in predicting the survival and prognosis of patients.Methods:A total of 2 267 patients with primary lung cancer in Shanxi Provincial Cancer Hospital from January 2007 to September 2018 were selected. All patients underwent primary lung cancer surgery without a second primary tumor. Gender, age, occupation, tumor site, pathological type, surgical path, surgical method, tumor stage and treatment were selected as the prognostic factors. A Cox proportional hazard model was used to construct a prognostic index (PI) equation to calculate the PI value of each patient. According to the different ranges of PI values, the low-, intermediate- and high-risk prognosis groups were divided, and the survival status of three groups were evaluated.Results:Gender ( RR= 0.684, P= 0.001), age ( RR= 0.591, P < 0.01), occupation ( RR= 1.439, P= 0.001), pathological type ( RR= 3.694, P < 0.01), surgical path ( RR= 0.734, P= 0.001), tumor stage ( RR= 0.352, P= 0.007) were independent factors affecting the prognosis of patients with resectable lung cancer. Female, ≤65 years old, thoracoscopic surgery, and tumor stage Ⅰ were prognostic protective factors, and their risks of poor prognosis were reduced by 31.6%, 40.9%, 26.6%, and 64.8%, respectively. Farmer and adenosquamous carcinoma were prognostic risk factors, and their risks of poor prognosis were increased by 43.9% and 269.4%, respectively. The PI equation was ∑β ix i=-0.380 X 1-0.526 X 2+0.364 X 31+1.307 X 55-0.309 X 6-1.045 X 81 (X 1 was the gender, X 2 was the age, X 31 was the occupation as a farmer, X 55 was the pathological type of adenosquamous carcinoma, X 6 was the surgical path, X 81 was the tumor stage Ⅰ). PI <-1 was the low-risk group, PI ≥-1 and ≤-0.5 was the intermediate-risk group, PI >-0.5 was the high-risk group, and the differences of their survival rates were statistically significant ( P < 0.05). The 1-, 3-, and 5-year survival rates for the low-, risk groups were 96.8%, 87.0% and 77.9%; the intermediate-risk group were 91.8%, 82.2% and 61.7%; the high-risk group were 86.5%, 61.7% and 50.3%. respectively. Conclusion:The prognostic prediction model of resectable lung cancer can predict the prognosis risk and the corresponding survival rate of patients with resectable lung cancer, and it can help clinicians to evaluate the prognosis and formulate subsequent treatment plans.
ABSTRACT
Objective@#To explore the value of the constructed prognostic prediction model of resectable lung cancer in predicting the survival and prognosis of patients.@*Methods@#A total of 2 267 patients with primary lung cancer in Shanxi Provincial Cancer Hospital from January 2007 to September 2018 were selected. All patients underwent primary lung cancer surgery without a second primary tumor. Gender, age, occupation, tumor site, pathological type, surgical path, surgical method, tumor stage and treatment were selected as the prognostic factors. A Cox proportional hazard model was used to construct a prognostic index (PI) equation to calculate the PI value of each patient. According to the different ranges of PI values, the low-, intermediate- and high-risk prognosis groups were divided, and the survival status of three groups were evaluated.@*Results@#Gender (RR= 0.684, P= 0.001), age (RR= 0.591, P < 0.01), occupation (RR= 1.439, P= 0.001), pathological type (RR= 3.694, P < 0.01), surgical path (RR= 0.734, P= 0.001), tumor stage (RR= 0.352, P= 0.007) were independent factors affecting the prognosis of patients with resectable lung cancer. Female, ≤65 years old, thoracoscopic surgery, and tumor stage Ⅰ were prognostic protective factors, and their risks of poor prognosis were reduced by 31.6%, 40.9%, 26.6%, and 64.8%, respectively. Farmer and adenosquamous carcinoma were prognostic risk factors, and their risks of poor prognosis were increased by 43.9% and 269.4%, respectively. The PI equation was ∑βixi=-0.380 X1-0.526 X2+0.364 X31+1.307 X55-0.309 X6-1.045 X81 (X1 was the gender, X2 was the age, X31 was the occupation as a farmer, X55 was the pathological type of adenosquamous carcinoma, X6 was the surgical path, X81 was the tumor stage Ⅰ). PI <-1 was the low-risk group, PI ≥-1 and ≤-0.5 was the intermediate-risk group, PI >-0.5 was the high-risk group, and the differences of their survival rates were statistically significant (P < 0.05). The 1-, 3-, and 5-year survival rates for the low-, risk groups were 96.8%, 87.0% and 77.9%; the intermediate-risk group were 91.8%, 82.2% and 61.7%; the high-risk group were 86.5%, 61.7% and 50.3%. respectively.@*Conclusion@#The prognostic prediction model of resectable lung cancer can predict the prognosis risk and the corresponding survival rate of patients with resectable lung cancer, and it can help clinicians to evaluate the prognosis and formulate subsequent treatment plans.
ABSTRACT
Objective To detect the expressions of human telomerase tranacriptase (hTERT) and MMP-7 mRNA in the peripheral blood of patients with cardia cancer.Methods Total RNA was extracted with TRIzol and was transcribed reversely into cDNA.RT-PCR was used to detect mRNA expression of MMP-7 and hTERT in the peripheral blood of 157 patients with cardia cancer.81 patients without metastasis were followed up for 12 months.Results Of 157 patients,73 cases (46.0 ％) and 61 cases (38.8 ％) had the positive expressions of hTERT,MMP-7,respectively.There were significant correlations between the blood micro-metastases MMP-7 and hTERT expressions and TNM staging (x2 =10.624,14.530),tumor metastasis (x2 =7.294,12.824),and differentiation degree (x2 =12.003,6.482),but no significant correlations were seen in sex (x2 =2.597,0.199) and age (x2 =4.314,0.073).There was statistically significant in the occurrence rate of tumor metastasis between 6-month and 12-month follow-up.The occurrence rate of metastasis in patients with micro-metastases was 6.12-fold compared with patients without micro-metastases after 12-month follow-up.Conclusion Detection of MMP-7 and hTERT expressions can be used as reliable markers to predict peripheral blood micro-metastasis in patients with cardia carcinoma.
ABSTRACT
Objective To approach the reason and treatment of arrhythmia after total pneumonectomy. Methods 94 arrhythmic cases after total pneumonectomy surgery were reviewed, the arrhythmia's clinical types, developing reasons and treatment process were summarized. Results There are 34 arrhythmic cases (36.2%) in all the 94 patients, most of them are sinus tachycardia. The incidences of arrhythmic are about 22.5 % and 78.3 % for normal and abnormal ECG patients before operation. The incidences of arrhythmic are also about 24.2% and 28.1% for using PCEA or not using any pain killers after surgery. Conclusion Arrhythmia after total pneumonectomy was influenced by patients' age, previous medical history, suffered hypoxemia during operation and high cardiac irritability. Using interventional treatment for patients with cardiovascular disease before operation, give enough oxygen, keep respiratory tract ease and smooth and using analgesia can significantly decease the arrhythmic incidence after total pneumonectomy.